Abstract:Background: Dietary isoflavones are thought to be cardioprotective because of their structural similarity to estrogen. The reduction of concentrations of circulating inflammatory markers by estrogen may be one of the mechanisms by which premenopausal women are protected against cardiovascular disease. Objective: Our aim was to investigate the effects of isolated soy isoflavones on inflammatory biomarkers [von Willebrand factor, intracellular adhesion molecule 1, vascular cell adhesion molecule 1 (VCAM-1), E-selectin, monocyte chemoattractant protein 1, C-reactive protein (CRP), and endothelin 1 concentrations]. Differences with respect to single-nucleotide polymorphisms in selected genes [estrogen receptor alpha (XbaI and PvuII), estrogen receptor beta [ERbeta (AluI) and ERbeta[cx] (Tsp509I), endothelial nitric oxide synthase (Glu298Asp), apolipoprotein E (Apo E2, E3, and E4), and cholesteryl ester transfer protein (TaqIB)] and equol production were investigated. Design: One hundred seventeen healthy European postmenopausal women participated in this randomized, double-blind, placebo-controlled, crossover dietary intervention trial. Isoflavone-enriched (genistein-to-daidzein ratio of 2:1; 50 mg/d) or placebo cereal bars were consumed for 8 wk, with a washout period of 8 wk between the crossover. Plasma inflammatory factors were measured at 0 and 8 wk of each study arm. Results: Isoflavones improved CRP concentrations [odds ratio (95% CI) for CRP values >1 mg/L for isoflavone compared with placebo: 0.43 (0.27, 0.69)]; no significant effects of isoflavone treatment on other plasma inflammatory markers were observed. No significant differences in the response to isoflavones were observed according to subgroups of equol production. Differences in the VCAM-1 response to isoflavones and to placebo were found with ERbeta AluI genotypes. Conclusion: Isoflavones have beneficial effects on CRP concentrations, but not on other inflammatory biomarkers of cardiovascular disease risk in postmenopausal women, and may improve VCAM-1 in an ERbeta gene polymorphic subgroup.

[Effect of Equol of a Isoflavone Metabolite on Menopausal Symptoms].

New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women

Urinary equol is associated with bioavailable testosterone but not total testosterone in women

[Equol-Producing Phenotype and in Relation to Serum Sex Hormones among Healthy Adults in Beijing].

[Effect of Soy Isoflavones on Peri-Menopausal Symptom and Estrogen].

Comparison of blood and urine concentrations of equol by LC‒MS/MS method and factors associated with equol production in 466 Japanese men and women

Prevalence of the Equol-Producer Phenotype and Its Relationship with Dietary Isoflavone and Serum Lipids in Healthy Chinese Adults

Association of equol with obesity in postmenopausal women

EFFECT OF SOY ISOFLAVONES ON MENOPAUSAL SYMPTOMS IN EARLY POSTMENOPAUSAL CHINESE WOMEN

Does genotype and equol-production status affect response to isoflavones? Data from a pan-European study on the effects of isoflavones on cardiovascular risk markers in post-menopausal women

Urinary Equol Excretion and Its Relation to Serum Lipid among Healthy Adults in Beijing

[Prevalence of Equol Producer Phenotype and Its Relations to Lifestyle Factors and Dietary Intakes among Lifestyle Factors and Dietary Intakes among Healthy Chinese Adults in Beijing].

Clinical effect of equol supplementation in the treatment of desquamative gingivitis with 1-year follow-up

(±)-Equol Interferes with the Secretion of Gonadotropin-Releasing Hormone and the Expression of Neuromodulators in Murine Neurons

Effect of Whole Soy and Isoflavones Daidzein on Bone Turnover and Inflammatory Markers: a 6-Month Double-Blind, Randomized Controlled Trial in Chinese Postmenopausal Women Who Are Equol Producers

Cardiovascular Risks in Relation to Daidzein Metabolizing Phenotypes among Chinese Postmenopausal Women

Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production

Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects

Effect of Whole Soy and Purified Isoflavone Daidzein on Renal Function--a 6-Month Randomized Controlled Trial in Equol-Producing Postmenopausal Women with Prehypertension.

The effect of chinese medicinal herbs in relieving menopausal symptoms in ovariectomized chinese women.

Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial